Cntn4 Gene Deficiency Promotes Autism-Like Phenotypes Associated with Gut Microbiota Perturbations and Gut-Brain Axis Metabolomic Alterations in Mice
Authors:
- 2 December 2025
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 235
Abstract
Autism spectrum disorder (ASD) involves complex genetic-environmental interactions, with the gut microbiota (GM)–brain axis playing a key role. To explore whether the ASD risk gene Cntn4 contributes to disease development via gut-brain connectivity, our study employed a Cntn4 knockout mouse model. The microbial diversity and abundance in the gut contents of these mice were assessed using 16S rDNA sequencing, while metabolite changes in the gut contents, serum, and cerebral cortex were detected via metabolomics methods. The results showed that Cntn4 gene knockdown induced autism-like behavioral changes and accelerated gut transit in mice. Compared with the control group, significant differences were observed in the composition of the GM and metabolomics profiles. Notably, alterations in GM (e.g., Adlercreutzia, Desulfovibrionaceae_unclassified) and disruptions in several metabolic pathways, including arginine–proline, histidine, sphingoid, tyrosine, and purine metabolism, were identified. Multi-omics analyses linked microbial shifts to metabolite changes in the gut contents, serum and cerebral cortex, particularly organic acids. These findings suggest that knockout of the Cntn4 gene may lead to autism-like changes in mice through mechanisms associated with alterations in GM and gut-brain axis metabolites. This study provides valuable insights into the mechanisms underlying ASD development and offers potential directions for the prevention and treatment of ASD.Keywords
Funding Information
- the Graduate Student Innovation Cultivation Foundation of Shenzhen University
- The National Natural Science Foundation of China (Grant NO. 31870825)
- the Shenzhen Bureau of Science, Technology and Information (No. JCYJ20170412110026229)
- the Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions (2023SHIBS0003)
This publication has 119 references indexed in Scilit:
- NEMO‐Binding Domain/IKKγ Inhibitory Peptide Alleviates Neuronal Pyroptosis in Spinal Cord Injury by Inhibiting ASMase‐Induced Lysosome Membrane PermeabilizationAdvanced Science, 2024
- Autism spectrum disorder: pathogenesis, biomarker, and intervention therapyMedcomm, 2024
- Investigating metabolic dysregulation in serum of triple transgenic Alzheimer’s disease male mice: implications for pathogenesis and potential biomarkersAmino Acids, 2024
- A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneityMedcomm, 2023
- Altered markers of mitochondrial function in adults with autism spectrum disorderAutism Research, 2023
- Alteration of the fecal microbiota in Chinese children with autism spectrum disorderAutism Research, 2022
- Profiles of urine and blood metabolomics in autism spectrum disordersMetabolic Brain Disease, 2021
- A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspectsPhytotherapy Research, 2019
- Molecular characterization and clinical features of a patient with an interstitial deletion of 3p25.3‐p26.1American Journal of Medical Genetics Part A, 2010
- Amino Acid Metabolism2001